The New England Journal of Medicine (NEJM) recently conducted a community poll on testosterone gel safety that concluded on December 2, 2014. The purpose of the poll was to get a clearer understanding of where the NEJM readers, who are primarily medical professionals, stand on prescribing products like testosterone gels to treat signs of aging, also known as low testosterone, or low T.
According to a Wall Street Journal article about the poll, it appears that a medical group in support of testosterone therapy may have undermined the poll through an email campaign advocating use of testosterone products.
Though it was first thought that the emails were widely circulated among the entire NEJM community, the Wall Street Journal later made a correction to their article, clarifying that the emails distributed by this pro-testosterone therapy group reached only other members of the group.
Even so, this discovery is alarming, especially in light of the fact that some members of the group have received thousands of dollars in perks from pharmaceutical companies responsible for manufacturing testosterone therapy products.
Though the NEJM poll is not the final word on testosterone therapy safety, the results nevertheless provide important insight into how the medical field is handling the issue.
Currently, prescribing testosterone gels for low T is not highly regulated, as the U.S. Food and Drug Administration (FDA) is in the midst of deliberating how to move forward in regards to these products.
In fact, a clear indicator that testosterone gel regulation is lacking in the U.S. is the fact that nearly a quarter of the patients who use some form of testosterone therapy product received their prescriptions without having to undergo testosterone level evaluations, according to the Wall Street Journal. This is a startling fact in light of studies having found a solid link between testosterone gels and cardiovascular complications.
In Canada, the country’s drug regulator has wasted no time in demanding updates to testosterone drug labels to reflect cardiovascular risks.
Legal Assistance for Anyone Injured by Testosterone Gels
Carey Danis & Lowe is a St. Louis law firm that specializes in testosterone gel lawsuits.
Our defective drug lawyers are currently accepting testosterone gel cases. If you or someone you love has been injured by testosterone gels, our lawyers are available to walk you through your legal options and compensation eligibility during a free, no-obligation case evaluation.
Contact the law offices of Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury claim form.References: Pharmaceutical litigation, Testosterone